Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Olaf Heidenreich

Newcastle AuthorsTitleYearFull text
Professor Olaf Heidenreich
Combination of targeted pharmacotherapy and immunotherapy with anti-CD19 CAR NK cells in acute lymphoblastic leukemia2025
Professor Olaf Heidenreich
A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia2024
Dr Hayden Bell
Dr Helen Blair
Samantha Jepson Gosling
Dr Martin Galler
Dan Astley
et al.		Combination p53 activation and BCL-xL/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia2024
Dr Sarah Fordham
Dr Wei-Yu Lin
Dr Helen Blair
Dr Claire Elstob
Dr Hayden Bell
et al.		Biallelic TET2 mutations confer sensitivity to 5′-azacitidine in acute myeloid leukemia2023
Dr Paul Sinclair
Dr Ruth Cranston
Prahlad Raninga
Joanna Cheng
Rebecca Hanna
et al.		Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia2023
Dr Hayden Bell
Dr Helen Blair
Mankaran Singh
Professor Anthony Moorman
Professor Olaf Heidenreich
et al.		Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia2023
Dr Jose Luis Marin-Rubio
Dr Maria Duenas Fadic
Dr Tiaan Heunis
Dr Abeer Dannoura
Dr Joe Inns
et al.		A Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Assay Identifies Nilotinib as an Inhibitor of Inflammation in Acute Myeloid Leukemia2022
Dr Ricky Tirtakusuma
Dr Katarzyna Szoltysek
Professor Vasily Grinev
Dr Sirintra Nakjang
Dr Daniel Williamson
et al.		Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia2022
Professor Vasily Grinev
Dr Sirintra Nakjang
Hesta McNeill
Dr Mojgan Reza
Dr Natalia Martinez Soria
et al.		RUNX1/RUNX1T1 mediates alternative splicing and reorganises the transcriptional landscape in leukemia2021
Professor Olaf Heidenreich
Venetoclax and dexamethasone synergize with inotuzumab ozogamicin–induced DNA damage signaling in B-lineage ALL2021
Mankaran Singh
Dr Helen Blair
Philip Berry
Professor Olaf Heidenreich
Multi-drug chemotherapy dose optimisation in preclinical leukaemia models using HPLC-MS/MS2020
Professor Olaf Heidenreich
Optimized induction of mitochondrial apoptosis for chemotherapy-free treatment of BCR-ABL+acute lymphoblastic leukemia2019
Dr Helen Blair
Professor Olaf Heidenreich
Subtype-specific regulatory network rewiring in acute myeloid leukemia2019
Dr Deepali Pal
Dr Helen Blair
Professor Olaf Heidenreich
Targeting the thioredoxin system as a novel strategy against B-cell acute lymphoblastic leukemia2019
Dr Paul Sinclair
Dr Helen Blair
Dr Sarra Ryan
Dr Lars Buechler
Joanna Cheng
et al.		Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 212018
1234567891011